http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007070227-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36eb00a5c4946507dd04f3fd4bbd3fbb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
filingDate 2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_350a5efb4092b1875c3d79ac98fe9cd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1515138e7372c507b50d4a3abe9e3f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e82ed907339fdd31049a751528e4c5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c3ab0a68a15c121ba18e1cba3ece17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e115881cf611048b39b27e1e8d5da9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7130159287a83bf0930729ddfda9866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89e8df0eba61d1aba3e4a9861dca6184
publicationDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007070227-A
titleOfInvention Artificial protein complex and use thereof
abstract The present invention provides an artificial protein complex that can be immobilized by controlling orientation with respect to a solid phase carrier. An artificial protein complex is formed by combining two polypeptides each having an α-helix portion and an N-terminal peptide chain and / or a C-terminal peptide chain adjacent to the α-helix portion at each α-helix portion. A cyclic structure in which the combined dimers are arranged in a ring, and a tag portion capable of exerting a covalent or non-covalent interaction is preferentially provided on one end side of the circular structure. Configure as follows. [Selection] Figure 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008267890-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112410209-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010063453-A
priorityDate 2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005098726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001083155-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID436947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450542361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00639
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9735431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24644
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1442179
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ767J3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9YGI5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496967
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4AEE3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26433
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451839851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448452169
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395725
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415730263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448761043
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18998
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62080
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO42446
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24586
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11936
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453706507
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486281
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID56196
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1074
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62852
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23683938
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1442179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24855
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID56196
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1074
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID288583

Total number of triples: 84.